Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

SCOTUS pauses Purdue Pharma bankruptcy plan over whether it can shield founders from opioid liability The company said they are "confident in the legality" of their approach.

Purdue Pharma's bankruptcy entered a new, possibly final phase this week when the drugmaker filed a new $7.4 billion plan to resolve thousands of lawsuits that alleged its OxyContin pain ...

Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after it faced scores of lawsuits related to the opioid crisis.

(WJET/WFXP) — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller ...

The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local ...

NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback ...

Purdue Pharma files new bankruptcy plan to settle opioid lawsuits. Sackler family to pay $1.5 billion on settlement date, with $6.5 billion over 15 years.

Purdue Pharma files new bankruptcy plan to settle opioid lawsuits. Sackler family to pay $1.5 billion on settlement date, with $6.5 billion over 15 years.